HOME >> MEDICINE >> NEWS
ESC highlights need for screening and global risk management as statins move over the counter in UK

Today Dr John Reid, the Health Secretary for the United Kingdom (UK), announced the reclassification of statins as 'over the counter' products in the UK, to be available to members of the public directly from pharmacists without the need for a prescription. With this move, recently approved by the UK's Committee on Safety of Medicines, the UK is the first country to move a statin from prescription-only to over the counter access.

The initial statin to be available from pharmacists will be simvastatin, at a daily dosage of 10mg. Simvastatin will be targeted at individuals with a low to moderate risk of heart disease, specifically sub-populations such as men aged 50 years and over and women aged 55 and over with one or more risk factors including: obesity, cigarette smoking, insufficient physical exercise, unhealthy diet, hypertension, diabetes or family history of heart disease. An on-the-spot blood test is envisaged to assess if an individual requesting simvastatin is eligible and if the results are positive the treatment can be purchased immediately.

As a result of this decision, UK health authorities expect to increase the usage of statins in primary prevention, in order to reduce cholesterol levels in the UK population and ultimately reduce the country's high incidence of heart disease, arguing that the move is in favour of improving patient choice and access to medicines.

Statins not a stand-alone prevention measure

In light of this development, the European Society of Cardiology (ESC) stresses the importance of viewing statins appropriately within the global risk management environment.

Simvastatin, along with the other statins in its class, is a very effective treatment option in both primary and secondary cardiovascular disease prevention. However, it is by no means a substitute for lifestyle factor improvements and should only be taken in parallel to effective risk factor reduction methods such as health
'"/>

Contact: Camilla Dormer
cdormer@escardio.org
33-49-294-8627
European Society of Cardiology
12-May-2004


Page: 1 2 3

Related medicine news :

1. Other highlights in the March 16 JNCI
2. Other highlights in the March 2 JNCI
3. Other highlights in the February 2 JNCI
4. Article highlights confusion about Homeland Security safety symbols
5. Other highlights in the January 19 JNCI
6. US study highlights clear link between increased fast-food consumption and obesity
7. Other highlights in the December 15 JNCI
8. European study highlights persistent 3 decade increase in childhood cancer incidence
9. Other highlights in the December 1 JNCI
10. Ugandan study highlights best drug combinations for treating malaria in Africa
11. Study highlights importance of pesticide worker dermal exposure

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/19/2017)... ... August 18, 2017 , ... ... at creating a transparent, verifiable database to help the cannabis industry move towards ... Paragon hopes to deliver a faster technology with lower fees. Paragon will build ...
(Date:8/19/2017)... ... August 19, 2017 , ... Praeclarus Press has ... These illustrations show the diversity of the breastfeeding mothers, using bright colors ... of sizes. These illustrations are also available on tote bags, notepads, smartphone cases, ...
(Date:8/19/2017)... ... August 19, 2017 , ... “Congratulations! It's A Boy! ... children to both their parents and God. “Congratulations! It's A Boy! God’s Gift: A ... a couple from Long Island, New York. , Published by Christian Faith Publishing, Dale ...
(Date:8/18/2017)... York, New York (PRWEB) , ... ... ... International Courier, LLC, d/b/a Quick International, LLC (“Quick”), a highly specialized asset-light ... announced it has entered into a definitive agreement to purchase Unitrans International ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... devices. Through an educational webinar, they will present the line of epMotion automated ... learn how easy you can automate everyday pipetting tasks. , Ideal for scientists ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... , Aug. 7, 2017  Endo International plc (NASDAQ: ... agreements to resolve virtually all known U.S. mesh product ... to resolve the known remaining U.S. claims at reasonable ... beginning in the fourth quarter of 2017 and continuing ... its second quarter 2017 results, the Company intends to ...
(Date:8/2/2017)... Calif. , Aug. 2, 2017 ... Continental Who,s Who as a Pinnacle Lifetime Professional ... the Key Account Manager at Turing Pharmaceuticals, AG. ... negotiations, troubleshooting and relationship building.                ... has more than 25 years of experience as ...
(Date:8/1/2017)... 2017   CerSci Therapeutics , a non-opioid drug ... , has received notice from the National Institute on ... (NIH) that it has been awarded a Direct-to-Phase II ... in 2017 with an additional $1,000,000 to follow in ... application of their lead non-opioid drug candidate CT-044 to ...
Breaking Medicine Technology:
Cached News: